Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00243789 · ClinicalTrials.gov registry record · Phase 1
Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy
A Phase 1 study, sponsored by Cooperative International Neuromuscular Research Group.
- Completed
- Registry status
- Phase 1
- Development phase
- 64
- Enrollment target
NCT00243789 is a Phase 1 study that has completed, run by Cooperative International Neuromuscular Research Group. The registered enrollment target is 64 participants.
The verdict
NCT00243789, a Phase 1 study, has completed, sponsored by Cooperative International Neuromuscular Research Group.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this study is to see if male children with Duchenne muscular dystrophy (DMD) have changes in strength when given the drug Pentoxifylline as a rescue treatment. A total of 64 subjects are expected to participate through all other centers of the Cooperative International Neuromuscular Research Group (CINRG) worldwide. The primary purpose of this study is to see whether the addition of pentoxifylline to a steroid regimen is effective in treating deteriorating muscle strength by comparing the muscle strength of PTX treated subjects and placebo treated subjects.
Interventions
- DRUG Pentoxifylline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00243789
The ClinicalTrials.gov registry entry for NCT00243789 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cooperative International Neuromuscular Research Group, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pentoxifylline is the first listed.
NCT00243789 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00243789 about?
NCT00243789 is a clinical study titled "Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy". The purpose of this study is to see if male children with Duchenne muscular dystrophy (DMD) have changes in strength when given the drug Pentoxifylline as a rescue treatment. A total of 64 subjects are expected to participate through all other centers of the Cooperative International Neuromuscular R...
What is the current status of trial NCT00243789?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 64 participants. The study started on 2005-09. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00243789?
The interventions under investigation include: Pentoxifylline (DRUG).
Who is sponsoring clinical trial NCT00243789?
This trial is sponsored by Cooperative International Neuromuscular Research Group, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.